Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Generic medicine
Generic medicine

Terbinafine

Terbinafine

Data statusRegistration & price fields require source verification.
57brands/products
36companies
57with current prices
Advertisement · clearly labelled sponsored placement
Pakistan brand index

Available brands

57 results
Reset
BrandManufacturerStrengthFormPackReg. no.Official price
AlafinHealth care pharmaceuticals1%Cream10gm104591PKR 276.272025-08-27
Binalfine W/WHorizon Healthcare (pvt.) ltd.1 %Cream10gm085350PKR 294.422026-07-27
BinazSearle IV Solutions (Pvt) Ltd.1 %Cream10gm078621PKR 294.422026-07-23
CawedaHiranis Pharmaceuticals Pvt. Ltd.10 mg/g (1%)Cream10gm076521PKR 294.422026-07-22
CUTISTABROS PHARMA (PVT). LTD.1% w/w (10 mg/g)Cream10 Gm035397PKR 294.422026-07-27
CUTISTABROS PHARMA (PVT). LTD.1% w/vLotion20ML067109PKR 578.222026-07-27
CUTISTABROS PHARMA (PVT). LTD.1%Gel10Gm058518PKR 204.642026-07-27
CUTISTABROS PHARMA (PVT). LTD.10 mgGel120ml107447PKR 2,318.552026-07-27
DanabidDanas Pharmaceuticals (Pvt) Ltd.1 %Cream10g083674PKR 280.562025-11-18
DaskilCRYSTOLITE PHARMACEUTICALS1 %Cream10gm077624PKR 294.422026-07-27
DavischollDavis Pharmaceutical Laboratories1 %Cream10gm117488PKR 334.572026-06-30
DynasilCCL Pharmaceuticals (Pvt.) Ltd.1 %Cream10gm096615PKR 332.992026-07-23
Exil w / wNimrall Laboratories1 %Cream10gm066232PKR 269.812024-07-01
GoterGlitz Pharma1% w/wCream10 gm038599PKR 280.562025-09-04
Lami-MedMediate Pharmaceutical Pvt Ltd125 mgTablet10’s107459PKR 542.472026-01-27
Lami-MedMediate Pharmaceutical Pvt Ltd250 mgTablet10’s107460PKR 866.572026-01-27
LamisilHaleon Pakistan Limited10 mgCream15gm083996PKR 319.592024-07-01
LamisilHaleon Pakistan Limited1 %Cream10gm084005PKR 319.592024-07-01
MycodermNabiqasim Industries (Pvt) Ltd.,1%Cream15gm085592PKR 404.762026-07-23
MycodermNabiqasim Industries (Pvt) Ltd.,1 %Cream10gm085592PKR 294.422026-07-23
Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.